5-MeO-MIPT

Introduction to 5-MeO-MIPT

[​IMG]

Using 5-MeO-MIPT

Ways of administration

5-MeO-MiPT Dosages - Oral (As per Erowid):
Threshold: 1 - 2 mg
Light: 2 - 4 mg
Common: 4 - 6 mg
Strong: 5 - 12 mg
Heavy: 15+ mg

5-MeO-MiPT Dosages - Smoked (As per Erowid):
Common: 10 - 15 mg
Strong: 15 - 20 mg
Heavy: 20+ mg

5-MeO-MiPT is generally taken orally, most often in a gelcap or wrapped in paper and
"parachuted". Uniquely, when smoked, 5-MeO-MiPT requires a higher dosage than other ROA's. This is in contrast to virtually all known tryptamines; generally, when smoking, less material is required, not more.

5-MeO-MiPT can be insufflated, but there is little information on this ROA that has been published.

Effects of 5-MeO-MIPT

5-MeO-MiPT can produce extremely variable reactions in different people. As with any psychedelic drug, overly intense or scary experiences are a real possibility; it should be stressed that "eyeballing" the amount of the drug to be used is an incredibly bad idea with this substance. Accurate scales should always be available to anyone even considering working with research chemicals. As a substance that's active in the single-milligram dosage range, over-estimating a dose would be very easy to do; this could end up being dangerous to the user or those around them.

Many of the effects of 5-MeO-MiPT are similar to the effects caused by 5-MeO-DiPT, including (As per Erowid):

POSITIVE
  • euphoria, mood lift
  • increased tactile sensations
  • sensory enhancement (taste, smell, etc)
  • sexually interesting
  • emotional opening
  • relaxation
  • powerful "rushing" sensation (smoked)
  • immersive experiences (smoked)

NEUTRAL
  • feelings of body & muscle energy, buzzing
  • visual distortions
  • color intensification ( higher doses / smoked)
  • disorientation (smoked)
  • sometimes dissociation (smoked)
  • tremor (smoked)
  • emotional lability (smoked)

NEGATIVE
  • possible stomach discomfort, gas & vomiting
  • anxious stimulation
  • muscle tension / discomfort
  • difficulty sleeping for 4-8 hours after peak in some people
Many users have noted that 5-MeO-MiPT has a very distinct biphasic nature, and presents its effects very differently during different periods of the trip. Most users report that the drug's effects begin as stimulating and have a very "roll"-like characteristic, somewhat akin to MDMA. As the user begins to peak, however, this stimulation gradually becomes very psychedelic in nature. The tacticle enhancement fades as visuals begin to take over. Often, because of this biphasic quality, the experience from 5-MeO-MiPT is best described as a "tryptamine-roll"; the experience can best be summed up as having the quality of both MDMA and DMT, but without combining the two.

Combinations with 5-MeO-MIPT

Different Uses for 5-MeO-MIPT

Pharmacology of 5-MeO-MIPT

5-MeO-MiPT's psychedelic effects are most likely mediated by 5-HT2a receptor agonism, as is the case with other tryptamines like Psilocybin or DMT.

Chemistry of 5-MeO-MIPT

The dangers of 5-MeO-MIPT

According to many reports from those who have used the drug, peripheral vasoconstriction can be a problem with this chemical. At least one user relayed that after a 20mg oral dose, his lips had taken on a bluish tint. This could be a dangerous side-effect if one has other pre-existing health issues of note.

These are the dangers common to all psychedelic drugs:

Accidental injury. When on a psychedelic drug, it is easier to accidentally injure yourself. Also because of the disorientating and potentially delusion inspiring nature of the experience, you could be lead to inflict harm on others or yourself. People have fallen off rooftops, run into traffic, attempted to throw people off rooftops as 'sacrifices', drowned, and so on. The best way of protecting against this is to have a friend with you who is sober to look after you and handle any negative situation that might arise.

Bad trips. A bad trip is a negative psychedelic experience. It can range from a mildly negative feeling of anxiety/discomfort, to full-blown psychosis. Bad trips usually ruin a psychedelic experience for the tripper and everyone else. Most bad trips are manageable, just very uncomfortable and difficult. Some are extreme and unmanageable though. It's not uncommon for a bad trip to result in lingering psychological issues. Usually just a few days of negative emotions and anxiety. Sometimes, however, a week or so of serious anxiety, destabilized mental state and impaired functioning is possible. On very rare occasions, a month or two of severely diminished functioning, traumatized mental state, depression & crippling anxiety can occur. More information on bad trips can be found here. The best way of avoiding a bad trip is having the correct set and setting.

Permanent psychosis. Psychedelics are believed by researchers not to cause permanent psychosis, however they could trigger a latent mental illness in someone who was already predisposed to it, or make existing mental illnesses worse. If there is a history of mental illness in your family, you are more likely to be predisposed. Everyone is at some risk, however.

PTSD, anxiety disorder, depression & depersonalization. There are anecdotal reports of the trauma inflicted by some bad trips leading to depression and anxiety which while usually temporary, could potentially develop into lasting disorders. While no different to the potential of any traumatic event to cause lasting disorders, nonetheless this is a danger of psychedelic drug use.

Producing 5-MeO-MIPT

Forms of 5-MeO-MIPT

5-MeO-MiPT is generally available as a white or off-white powder.

Appearance

Legal status of 5-MeO-MIPT

United Nations

USA

5-MeO-MiPT is not explicitly scheduled in the USA; however, it is an analogue of 5-MeO-Diisopropyltryptamine (5-MeO-DiPT, or Foxy Methoxy), which is a Schedule I substance. As such, 5-MeO-MiPT is, without a doubt, covered by the Federal Analogue Act and is illegal to own or trade for the purposes of human consumption.

EU

Other Countries

History of 5-MeO-MIPT

5-MeO-MiPT is a research chemical; as such, it has virtually no established safety profile. It has an extremely short history of use, and was likely first synthesized by Alexander Shulgin. No long term health-effects from the substance or other information are available at this time.

More 5-MeO-MIPT Sections

The latest 5-MeO-MIPT threads




References

This page has been seen 27,957 times.